SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark reports positive data in Phase 2a study of ‘GBR 830’

01 Aug 2017 Evaluate

Glenmark Pharmaceuticals has reported a positive data from a Phase 2a study of GBR 830, an investigational, anti-OX40 monoclonal antibody, in atopic dermatitis (AD), a common and serious chronic skin disease. The study evaluated the safety, biological and clinical activity, and pharmacokinetics of GBR 830, relative to placebo, in adults with moderate-to-severe AD with history of inadequate response to topical therapies.

Based on the results of this Phase 2a study, Glenmark is firmly committed to advancing GBR 830 for patients with AD and plans to initiate a Phase 2b trial in the first half of calendar year 2018. Glenmark is planning to submit these data for presentation at upcoming scientific meetings and publication in a peer-reviewed journal.

Glenmark Pharmaceuticals is a global innovative pharmaceutical company with operations in more than 50 countries. Glenmark has a diverse pipeline with several compounds in various stages of clinical development, primarily focused in the areas of oncology, respiratory disease, and dermatology.


Glenmark Pharma Share Price

2358.75 -5.60 (-0.24%)
11-May-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1882.50
Dr. Reddys Lab 1290.55
Cipla 1339.80
Zydus Lifesciences 945.35
Lupin 2254.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×